Targeting Surface Nucleolin With Multivalent HB-19 and Related Nucant Pseudopeptides Results in Distinct Inhibitory Mechanisms Depending on the Malignant Tumor Cell Type

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-11-333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Distinct Glucose-Lowering Mechanisms of Ipragliflozin Depending on Body Weight Changes

Drugs in R and D
Pharmacology
2016English

Derlin-1 Is Overexpressed on the Tumor Cell Surface and Enables Antibody-Mediated Tumor Targeting Therapy

Clinical Cancer Research
Cancer ResearchOncology
2008English

The Anti-Hiv Pentameric Pseudopeptide HB-19 Is Preferentially Taken Up in Vivo by Lymphoid Organs Where It Forms a Complex With Nucleolin

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2001English

Subordination Results on Multivalent Functions Related to the Saigo Fractional Differintegral Operator

Fractional Differential Calculus
2015English

Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature

Cancer Research
Cancer ResearchOncology
2016English

Cell-Surface Nucleolin Acts as a Central Mediator for Carcinogenic, Anti-Carcinogenic, and Disease-Related Ligands

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2014English

Targeting Tumor-Related Immunosuppression Using Metronomic Cyclophosphamide in Combination With Lenalidomide -New Mechanisms for Old Drugs

Chemotherapy: Open Access
2012English

Functionalization of Iron Oxide Magnetic Nanoparticles With the Multivalent Pseudopeptide N6l for Breast Tumor Targeting

Journal of Nanomedicine & Nanotechnology
2015English

Targeting Homologous Recombination Using Imatinib Results in Enhanced Tumor Cell Chemosensitivity and Radiosensitivity

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy